What Are The Recommended Operating Parameters And Clinical Endpoints When Using Ablative Laser Systems For Trichoepitheliomas? Ablate Just Below Skin

For trichoepitheliomas, the key endpoint is controlled ablation—not maximum depth. Ablate to a level just below the adjacent normal skin surface. Typical continuous-wave settings are a 1–3 mm spot size at 2–5 W, while UltraPulse systems commonly use 200–250 mJ; exact parameters must be adjusted for the device, lesion thickness, location, and tissue response.

The balance is precise: superficial ablation promotes early recurrence, while excessive depth causes permanent scarring. The laser should remove the lesion to just below the surrounding skin level while preserving the deeper dermis.

Establishing the Correct Treatment Endpoint

Aim for a slightly subadjacent surface

The desired endpoint is ablation just below the level of adjacent normal skin. This provides adequate removal of the clinically evident lesion without unnecessarily extending into deeper dermal structures.

The endpoint should be judged visually and tactically by an experienced operator, not by a fixed energy value alone. Laser settings are starting points; tissue response determines when treatment should stop.

Avoid superficial treatment

If residual tumor remains above or near the treatment base, the lesion may recur early. This is particularly relevant when treating larger, thicker, or plaque-like trichoepitheliomas.

Avoid deep dermal injury

Ablation deeper than necessary increases the risk of permanent scarring. The risk is especially important in cosmetically sensitive areas and where the skin is thin.

Recommended Operating Parameters

Continuous-wave laser systems

For CW systems, the reference range is:

Spot size: 1–3 mm
Power: 2–5 W

These settings are generally used for controlled vaporization or debulking. The operator should use the lowest effective exposure that reaches the desired subadjacent endpoint.

UltraPulse systems

For UltraPulse operation, a typical energy range is:

Energy: 200–250 mJ

A pulsed approach may also use approximately 200–250 mJ with a 1 mm spot, depending on the device configuration and treatment technique.

Energy values cannot be transferred directly between different laser platforms. Pulse duration, delivery mode, beam profile, repetition rate, and tissue hydration all affect the actual ablation and thermal effect.

Er:YAG versus CO₂ systems

Modulated Er:YAG lasers are advantageous when precise tissue removal and minimal thermal collateral damage are priorities. This can be useful for lesions where careful control of the ablation depth is more important than extensive coagulation.

CO₂ systems may provide more thermal coagulation and hemostatic effect, but this also increases the need to control depth and thermal injury. A clinician may use Er:YAG for initial ablation and low-power CO₂ treatment for limited coagulation or hemostasis in selected larger lesions.

Adapting Treatment to Lesion and Location

Small, superficial lesions

Small lesions can generally be treated with controlled, focal ablation using a small spot and conservative exposure. The operator should reassess the surface frequently rather than applying repeated passes automatically.

Large or plaque-form lesions

Larger lesions may require staged debulking or a combination approach. The reported technique of initial Er:YAG ablation followed by approximately 5 W low-power CO₂ coagulation may help manage tissue removal and hemostasis, but it should not be interpreted as a universal protocol.

Periocular and eyelid lesions

Periocular skin requires more conservative treatment than typical facial skin because it is thin and vulnerable to scarring, retraction, and ectropion. Energy density and the number of passes should be reduced relative to standard facial protocols.

Treatment boundaries should be feathered, particularly near the periphery. Fewer passes at the edge help avoid a visible transition between treated and untreated skin.

Ocular protection

When treating eyelid or periorbital skin, internal metal corneoscleral shields are required before laser firing. Topical anesthetic may be applied beforehand, but it must be completely removed before shield placement and treatment.

Why Ablative Lasers Are Used

The lesions lack a useful vascular target

Trichoepitheliomas are skin-colored benign follicular tumors and generally do not provide the prominent hemoglobin target required for vascular-specific lasers. Their treatment therefore relies on physical tissue ablation, rather than selective photothermolysis of blood vessels.

Precision is more important than power

The objective is not to maximize vaporization. It is to remove the visible lesion while limiting thermal and mechanical injury to the surrounding and deeper tissue.

This is why modulated Er:YAG systems can be attractive when precision and reduced collateral thermal damage are priorities.

Understanding the Trade-offs

Recurrence versus scarring

The central trade-off is straightforward:

Too shallow: greater likelihood of early recurrence.
Too deep: increased likelihood of permanent scarring.

The correct endpoint lies between these outcomes: complete clinical debulking to just below the adjacent skin surface.

Coagulation versus thermal damage

CO₂ lasers can provide useful coagulation, particularly when treating larger or more vascular lesions. However, excessive power, prolonged exposure, or repeated passes can increase thermal injury and scarring risk.

Fixed settings versus tissue response

Published parameter ranges should be treated as starting guidelines, not guaranteed prescriptions. Laser model, beam mode, spot size, pulse characteristics, lesion morphology, anatomic site, and operator technique all influence the result.

Cosmetic improvement versus complete eradication

Ablative treatment can improve the contour and appearance of trichoepitheliomas, but recurrence remains possible if deeper or residual tumor is left behind. Conversely, pursuing complete removal at excessive depth may produce a worse cosmetic outcome than limited residual disease.

Applying the Parameters Safely

Treatment should be performed only by a clinician experienced with ablative lasers, relevant periocular anatomy, and management of scarring and ocular complications.

If your primary focus is precise superficial removal: Consider a modulated Er:YAG approach, using conservative energy and stopping at ablation just below the adjacent skin surface.
If your primary focus is continuous-wave treatment: Use the 1–3 mm spot and 2–5 W range as an initial framework, then adjust exposure according to the observed tissue endpoint.
If your primary focus is treatment of a large or plaque-form lesion: Consider staged debulking or an Er:YAG-plus-low-power-CO₂ strategy when clinically appropriate, with careful control of depth and hemostasis.
If your primary focus is periocular safety: Reduce energy density and passes, feather the margins, and use internal metal corneoscleral protection before firing the laser.
If your primary focus is minimizing recurrence: Ensure adequate ablation to the correct subadjacent endpoint rather than stopping at a merely superficial vaporization.

The safest and most effective protocol is the one that matches the laser’s delivery characteristics and reaches the correct clinical endpoint without unnecessary deep tissue injury.

Summary Table:

Parameter	Continuous Wave	UltraPulse
Spot size	1-3 mm	1 mm
Power/Energy	2-5 W	200-250 mJ
Endpoint	Controlled ablation just below adjacent normal skin
Key principle	Balance between superficial ablation (recurrence) and deep ablation (scarring)

Ready to enhance your practice with precise ablative laser solutions? BELIS offers a wide range of professional-grade medical aesthetic equipment designed for clinics and premium salons. Our advanced laser systems, including CO2 fractional and Erbium devices, are perfect for procedures like trichoepithelioma removal. Contact our experts today at Contact us for personalized support and cutting-edge technology.